Durect corp (DRRX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities
Net loss

-20,578

-25,322

-3,695

-34,509

-

-

-

-

-

-

-

Net loss

-

-

-

-

-22,663

-22,110

-21,452

16,200

-18,765

-22,898

-30,288

Adjustments to reconcile net loss to net cash used in by operating activities:
Sale of intellectual property rights for non-operating purposes

-

-

500

-

-

-

-

-

-

-

-

Depreciation and amortization

291

254

437

416

425

601

558

964

1,176

2,251

2,506

Stock-based compensation

2,108

2,998

2,605

2,655

2,660

3,080

3,426

4,320

6,641

7,802

11,430

Loss (gain) on impairment and disposal of fixed assets

-

-

-

-

-

-

-

73

-8

-74

-

Asset retirement obligation

-

-

-

-

-

-

-

-

-

-

383

Inventory write-down

255

291

2,259

687

303

1,227

574

193

242

249

487

Amortization of debt issuance cost

369

149

62

104

100

38

-

-

-

-

-

Loss on debt extinguishment

-

-

-

-9

-

-

-

-

-

-

-

Net amortization on investments

-87

-84

41

216

278

351

-

-

-

-

-

Changes in operating lease liabilities

215

-

-

-

-

-

-

-

-

-

-

Realized gain from sale of marketable equity security, net of tax

-

-

-

-

117

-

-

-

-

-

-

Changes in assets and liabilities:
Accounts receivable

556

-619

1,222

-1,068

100

-227

183

-1,282

-268

2,016

-2,355

Inventories

217

549

140

552

579

1,369

681

353

670

303

-190

Prepaid expenses and other assets

-786

15

1,115

-656

2,056

-854

-370

372

-1,099

1,405

-341

Accounts payable

520

69

-566

800

265

285

-1,049

511

293

-38

1

Accrued liabilities

2,894

1,594

1,594

1,419

1,385

1,200

3,734

-

-

2,246

-

Accrued and other liabilities

-

-

-

-

-

-

-

78

-1,464

-

-1,534

Contract research liabilities

2,248

571

51

208

217

29

-154

-878

-748

1,119

-5

Deferred revenue

22,679

-493

-1,072

-38

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-395

1,729

-591

-35,320

-5,466

20,682

-6,760

Total adjustments

31,679

5,572

2,352

7,216

1,830

7,550

6,004

-29,648

1,379

30,661

9,394

Net cash used in operating activities

11,101

-19,750

-1,343

-27,293

-

-

-

-

-17,386

7,763

-20,894

Cash flows from investing activities
Net cash used in operating activities

-

-

-

-

-20,833

-14,560

-15,448

-13,448

-

-

-

Sale of intellectual property rights for non-operating purposes

-

-

500

-

-

-

-

-

-

-

-

Purchases of property and equipment

155

93

69

147

225

204

69

290

2,467

256

294

Purchases of available-for-sale securities

31,866

9,588

8,373

24,400

-

-

-

-

-

-

-

Purchases of available-for-sale securities

-

-

-

-

34,040

31,472

20,403

25,155

30,320

67,150

46,894

Proceeds from sales of available-for-sale securities

-

-

-

-

-

-

-

-

349

2,207

1,154

Proceeds from maturities of available-for-sale securities

4,697

14,218

20,632

30,584

40,619

16,294

21,580

29,352

47,172

59,069

35,651

Proceeds from sales of short-term investment

-

-

-

-

178

-

-

-

-

-

-

Net cash provided by investing activities

-

-

-

-

6,532

-15,382

1,108

3,907

-

-

-

Net cash provided by investing activities

-27,324

4,537

12,690

6,037

-

-

-

-

14,734

-6,130

-10,383

Cash flows from financing activities
Payments on equipment financing obligations

7

9

14

19

21

17

9

8

15

48

43

Net proceeds from issuances of common stock upon exercise of stock options, and purchases of ESPP shares

1,979

1,725

649

410

1,175

399

315

231

-

-

-

Payment on debt obligations

-

-

-

-

-

-

-

-

-

-

240

Net proceeds from issuances of common stock

18,360

16,780

11,989

23,745

14,290

4,618

10,675

11,617

1,126

565

528

Term loan amendment cost

829

1,014

-

173

240

-

-

-

-

-

-

Payment of final payment for term loan

-

-

-

886

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

903

-5,156

-3,359

-

-

-

-

Net proceeds from issuance of common stock in connection with equity financing

-

-

-

-

-

-

-

-

-

-

9,874

Net cash provided by financing activities

19,503

17,482

12,624

23,077

-

-

-

-

1,111

517

10,119

Net proceeds from issuance of term loan

-

-

-

-

-

19,786

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

15,204

24,786

10,981

11,840

-

-

-

Net decrease in Cash, cash equivalents, and restricted cash

3,280

2,269

23,971

1,821

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

2,299

-1,541

2,150

-21,158

Supplemental disclosure of cash flow information
Cash paid for interest

1,942

1,886

1,703

1,611

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

1,595

691

6

7

5

5

27

Supplementary disclosure of non-cash financing information
Fully vested options issued to settle accrued liabilities

994

1,860

1,600

1,143

1,007

-

-

-

-

-

-

Operating lease right-of-use assets obtained in exchange for operating lease obligations

7,329

-

-

-

-

-

-

-

-

-

-